Vertex seeks to mobilise Sh5 billion for the Bond Fund through the issuance of 50 million units, and a further Sh5 billion ...

By keeping issuance disciplined, the BoT ensures that lower policy rates do not trigger excessive liquidity growth that could ...

Vertex SME Holdings Limited, a private equity vehicle managed by JMMB Securities Limited, is gearing up to raise another $1 billion to fund its pipeline of investment opportunities. Private equity ...

NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most ...

ALYFTREK brings a potentially transformative therapy to up to 60 people living with CF in Canada who were not previously eligible for a CFTR modulator. As the first once-daily CFTR modulator ...

Vertex Announces Marketing Authorization in Canada for ALYFTREK, a Once-Daily Next-Generation CFTR Modulator for the Treatment of Cystic Fibrosis Français ...

Vertex Pharmaceuticals Incorporated stands second on our list and has recently launched the first non opioid acute pain treatment.

Vertex Pharmaceuticals, trading at US$472.35, is significantly undervalued with a fair value estimate of US$856.56. The company is expected to achieve profitability within three years and boasts ...

TANZANIA is making notable progress in fostering a knowledge-based economy through the development and strengthening of its Technology and Innovation Support Centres (TISC) network.

Tanzania is expected to close a deal with Nairobi that will see the neighbouring country use Kenya’s power transmission network to import up to 100 Megawatts (MW) electricity from Ethiopia.

The company also holds interests in multiple other licenses. This new venture in Tanzania underscores FIRST E&P's commitment to expanding its footprint and contributing to Africa's energy future.